Updates are available Correction dated 2024-02-05
Click to view Correction: https://doi.org/10.1038/s41467-024-45552-0
-
Authors
Young, Isabella C.
Massud, Ivana
Cottrell, Mackenzie L.
Shrivastava, Roopali
Maturavongsadit, Panita
Prasher, Alka
Wong-Sam, Andres http://orcid.org/0000-0001-7997-6126
Dinh, Chuong
Edwards, Tiancheng
Mrotz, Victoria
Mitchell, James
Seixas, Josilene Nascimento
Pallerla, Aryani
Thorson, Allison
Schauer, Amanda
Sykes, Craig
De la Cruz, Gabriela
Montgomery, Stephanie A. http://orcid.org/0000-0001-8012-5302
Kashuba, Angela D. M.
Heneine, Walid
Dobard, Charles W. http://orcid.org/0000-0002-9194-1775
Kovarova, Martina
Garcia, J. Victor http://orcid.org/0000-0003-3726-0482
Garcίa-Lerma, J. Gerardo http://orcid.org/0000-0001-6437-7745
Benhabbour, S. Rahima http://orcid.org/0000-0002-4738-5871
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI131430, R01AI162246, R01AI140799)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (KL2TR001109-04)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
National Science Foundation (DGE-1650116)
- License Information
-
More Information
Article History
Received: 16 September 2022
Accepted: 24 January 2023
First Online: 9 February 2023
Change Date: 5 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-45552-0
Competing interests
: S.R.B., I.C.Y., R.S., and P.M. are inventors on a patent describing the Injectable Polymer Based Drug Formulation for Ultra-Long-Acting Drug Delivery. J.G.G.-L. and W.H. are named in US. Government patents on “Inhibition of HIV infection through chemoprophylaxis”. J.G.G.-L.,. I.M., and W.H. are named in a US. Government patent on “HIV postexposure prophylaxis” and a US. Government patent application on “HIV pre-exposure prophylaxis”. The remaining authors declare no competing interests.
